HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-08-3121PMID 16234356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nomenclature for factors of the HLA system.

  2011cited by this paper
• Nomenclature for factors of the HLA system, 2004

  2005cited by this paper
• Nomenclature for Factors of the HLA System, 2004.

  2005cited by this paper
• Killer immunoglobulin-like receptors.

  2004cited by this paper
• Decreased Transplant Related Mortality and Better Survival in HLA Matched (12/12 A, B, C, DRB1, DQB1, DPB1) Unrelated Bone Marrow Transplants.

  2004cited by this paper
• HLA-DPB1 MISMATCH IN HLA-A-B-DRB1 IDENTICAL SIBLING DONOR STEM CELL TRANSPLANTATION AND ACUTE GRAFT-VERSUS-HOST DISEASE

  2004influential reference
• Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

  2004cited by this paper
• Tissue typing in support of unrelated hematopoietic cell transplantation.

  2003cited by this paper
• Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor β loci sequences

  2003cited by this paper
• Long‐term follow‐up of relapsed childhood acute lymphoblastic leukaemia

  2003cited by this paper
• Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.

  2003cited by this paper
• The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation

  2003cited by this paper
• The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.

  2002cited by this paper
• DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation

  2002cited by this paper
• Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.

  2002cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation

  2001cited by this paper
• HLA diversity, differentiation, and haplotype evolution in Mesoamerican Natives.

  2001cited by this paper
• Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901.

  2001cited by this paper
• HLA-DP Allele-Specific T Cell Responses to Beryllium Account for DP-Associated Susceptibility to Chronic Beryllium Disease1

  2001cited by this paper
• Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations.

  2001cited by this paper
• Peripheral blood stem cell allograft rejection mediated by CD4+ T lymphocytes recognizing a single mismatch at HLA-DPβ1*0901

  2001cited by this paper
• A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.

  2000cited by this paper
• Is there a graft‐versus‐leukaemia effect in the absence of graft‐versus‐host disease in patients undergoing bone marrow transplantation for acute leukaemia?

  2000cited by this paper
• The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor–recipient pairs

  2000cited by this paper
• Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.

  1999cited by this paper
• Locus and population specific evolution in HLA class II genes

  1999cited by this paper
• Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation

  1999cited by this paper
• Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets

  1998cited by this paper
• Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus.

  1998cited by this paper
• HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis.

  1998cited by this paper
• The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).

  1996cited by this paper
• Unrelated donor bone marrow transplantation for hematological malignancies-current status.

  1996cited by this paper
• HLA-DP and allogeneic bone marrow transplantation.

  1994cited by this paper
• Polymorphism, recombination, and linkage disequilibrium within the HLA class II region.

  1992cited by this paper
• Severe acute graft-versus-host disease by HLA-DPB1 disparity in recombinant family of bone marrow transplantation between serologically HLA-identical siblings: an application of the polymerase chain reaction-restriction fragment length polymorphism method.

  1991cited by this paper
• Graft-versus-leukemia reactions after bone marrow transplantation.

  1990cited by this paper
• T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP

  1989cited by this paper
• T lymphocyte cloning from rejected human kidney allograft. Recognition repertoire of alloreactive T cell clones.

  1988cited by this paper
• SB-restricted presentation of influenza and herpes simplex virus antigens to human T-Iymphocyte clones

  1983cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Outcomes of DPB1 Mismatch in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Time to Move Past Chromosome 6?

  2026cites this paper
• Differential Alloreactivity: Lessons Learned From a Singular HLA Locus

  2025cites this paper
• Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation.

  2025cites this paper
• HLA typing: A review of methodologies and clinical impact on haematopoietic cell transplantation.

  2024cites this paper
• Experimental Data on PIRCHE and T-Cell Reactivity: HLA-DPB1-Derived Peptides Identified by PIRCHE-I Show Binding to HLA-A*02:01 in vitro and T-Cell Activation in vivo

  2024cites this paper
• From clones to immunopeptidomes: New developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation.

  2024cites this paper
• MODELS OF HLA-DPB1 PERMISSIVENESS AND UNRELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION

  2024cites this paper
• Reduced human leukocyte antigen mismatching is associated with more favourable outcomes after unrelated donor haematopoietic stem cell transplantation

  2024cites this paper
• Improving unrelated donor equity: assessing mismatched donor opportunities with real world data in a minority-predominant cohort.

  2024cites this paper
• Human Leucocyte Antigen System and Selection of Unrelated Hematopoietic Stem Cell Donors: Impact of Patient–Donor (Mis)matching and New Challenges with the Current Technologies

  2023cites this paper
• Advanced Cell Therapy: Beyond the last Frontier in the Treatment of Cancer. A Historical Perspective Emphasizing the Work of Nobel Prize Laureates.

  2022cites this paper
• Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity

  2022cites this paper
• Present and future challenge for the use of stem cell in hematopoietic transplantation and cell therapy

  2021cites this paper
• The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis

  2021cites this paper
• Side-Population Trophoblasts Exhibit the Differentiation Potential of a Trophoblast Stem Cell Population, Persist to Term, and are Reduced in Fetal Growth Restriction

  2020cites this paper
• The HLA diversity of the Anthony Nolan register

  2020cites this paper
• Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional Hierarchies

  2020cites this paper
• Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.

  2019cites this paper
• HLA Matching in Unrelated Stem Cell Transplantation up to Date

  2019cites this paper
• (2019). Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study. Biology of Blood and Marrow Transplantation , 25 (3), 443-450.

  2019cites this paper
• Impact of HLA-DPB1 Matching on Outcome of Unrelated Transplant for Hematologic Malignant Diseases: A Systematic Review and Meta-analysis.

  2019cites this paper
• Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.

  2019cites this paper
• Extended HLA Haplotypes and Their Impact on DPB1 Matching of Unrelated HSCT Donors.

  2019cites this paper
• Unrelated Donor Selection for Stem Cell Transplants using Predictive Modelling

  2018cites this paper
• Système HLA – aspects fondamentaux et application à l’allogreffe de cellules souches hématopoïétiques

  2018cites this paper
• Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing

  2018cites this paper
• HLA typing—A case‐based approach to donor selection

  2018cites this paper
• Special Care of Blood and Marrow Hematopoietic Cell Transplant Recipient

  2018cites this paper
• Type : Spotlight

  2017cites this paper
• HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.

  2017influential citation
• MICA paired with mismatches in other loci that may lead to increased risk of GVHD5 are also warranted.

  2017cites this paper
• Impact of HLA-DPB1 Matching in Unrelated Allogeneic Stem Cell Transplantation: Results of Two Centers From Turkey

  2017cites this paper
• HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities.

  2017cites this paper
• Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis

  2017cites this paper
• Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT

  2016cites this paper
• Mismatched unrelated alternative donors for hematological malignancies.

  2016cites this paper
• High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities

  2015cites this paper
• GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT

  2015cites this paper
• Donor Selection for Hematopoietic Stem Cell Transplant Using Cost-Sensitive SVM

  2015cites this paper
• Donor Selection for Hematopoietic Stem Cell Transplant Using Cost-Sensitive SVM

  2015cites this paper
• Uloga alela gena HLA-DPB1 u ishodu transplantacije krvotvornih matičnih stanica s nesrodnog davatelja

  2014cites this paper
• A Multi-Site Study Employing High Resolution HLA Genotyping by Next Generation Sequencing

  2014cites this paper
• Sveučilište u Zagrebu Prirodoslovno - matematički fakultet Biološki odsjek

  2014cites this paper
• HLA allele and haplotype polymorphisms among Croatian patients in an unrelated hematopoietic stem cell donor search program.

  2014cites this paper
• Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.

  2014influential citation
• HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors

  2013cites this paper
• Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.

  2013cites this paper
• The HLA system in hematopoietic stem cell transplantation

  2013cites this paper
• Impact of Donor and Center Attributes on Outcomes of Hematopoietic Cell Transplantation

  2013cites this paper
• HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion.

  2013cites this paper
• transplantation factor for mortality after unrelated hematopoietic stem cell Nonpermissive HLA-DPB1 disparity is a significant independent risk

  2013cites this paper
• success of unrelated donor marrow transplantation High-resolution donor-recipient HLA matching contributes to the

  2013cites this paper
• Allogeneic transplantation: when is a mismatch better than a match?

  2013cites this paper
• Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision

  2013cites this paper
• NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome

  2012cites this paper
• Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.

  2012influential citation
• Characterization of the novel HLA-DPB1*140:01 allele identified by sequence-based typing.

  2012cites this paper
• A combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer

  2012cites this paper
• Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin.

  2012cites this paper
• Allelic and haplotypic HLA frequency distribution in Spanish hematopoietic patients. Implications for unrelated donor searching.

  2011cites this paper
• A multi-site study using high-resolution HLA genotyping by next generation sequencing.

  2011cites this paper
• Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation.

  2011cites this paper
• Tipificación molecular de los antígenos leucocitarios humanos, Estado del arte y perspectivas para los transplantes de células madre en Costa Rica

  2010cites this paper
• Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

  2010cites this paper
• Seleção de doador de medula óssea ou sangue periférico

  2010cites this paper
• Molecular typing of Human Leukocyte Antigens, State-of-theart and Perspectives for Stem cell Transplantation in Costa Rica

  2010cites this paper
• My approach to the immunogenetics of haematopoietic stem cell transplant matching

  2010influential citation
• The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation

  2010cites this paper
• HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

  2009cites this paper
• Emerging immunology of stem cell transplantation.

  2009cites this paper
• HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry

  2009cites this paper
• Fetal microchimerism and cancer.

  2009cites this paper
• High-resolution, high-throughput HLA genotyping by next-generation sequencing.

  2009cites this paper
• Non-Permissive HLA-DPB1 Disparity is a Significant Independent Risk Factor for Mortality after Unrelated Hematopoietic Stem Cell Transplantation Running Title: Nonpermissive HLA-DPB1 disparity in unrelated HSCT

  2009cites this paper
• MHC class I chain-related gene a (MICA) in unrelated donor transplantation

  2009cites this paper
• Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.

  2009cites this paper
• Stem Cell Transplantation for Hematologic Malignancies

  2008cites this paper
• Chapter 2 Stem Cell Transplantation for Hematologic Malignancies

  2008cites this paper
• Impact of HLA‐DPB1 allelic and single amino acid mismatches on HSCT

  2008cites this paper
• Should all unrelated donors for transplantation be matched?

  2008cites this paper
• Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant

  2008cites this paper
• Killer cell Immunoglobulin-like Receptor (KIR) polymorphism in Haematopoietic Stem Cell Transplantation (HSCT) : The effect of KIR gene and genotype polymorphism on clinical outcome after HSCT

  2008cites this paper
• Strategies of the donor search for children with second CR ALL lacking a matched sibling donor

  2008cites this paper
• Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match.

  2008cites this paper
• Impact of graft-versus-host disease on survival.

  2008cites this paper
• The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation

  2008cites this paper
• Principles and tools for selection of umbilical cord blood and unrelated adult donor grafts.

  2008cites this paper
• HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia

  2008cites this paper
• Optimal HLA matching in hematopoietic cell transplantation.

  2008cites this paper
• Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?

  2008cites this paper
• Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

  2007cites this paper
• Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors.

  2007cites this paper
• Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation.

  2007cites this paper
• Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

  2007cites this paper
• HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.

  2007cites this paper
• The importance of HLA-DPB 1 in unrelated donor hematopoietic cell

  2007cites this paper
• High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

  2007cites this paper
• The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.

  2007cites this paper
• Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.

  2007cites this paper